Clinical Trials on Influenza in United Kingdom

Total 1007 results

National Institute of Allergy and Infectious Diseases...

Completed

Clinical IGSP-CHOP Boston

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Inpatient Influenza Surveillance

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

T and B Cell Response to Avian Flu Vaccine

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza Antiviral DAS181-F03

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Higher Dose Intradermal H5 Vaccine

Influenza

United States
Theraclone Sciences, Inc.

Completed

Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza

Influenza, Human

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

H9 Priming Study in Healthy Adults

Influenza

United States
Functional Genetics Inc.
United States Department of Defense

Unknown

Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Th1 Response to Influenza: Aging and Vaccine Efficacy

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza Vaccine in Pediatric Transplant Subjects

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Proteomic Profiling for Influenza

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Proteomic Profiling for Influenza Vaccination - FluMist

Influenza

United States
The Cleveland Clinic

Completed

Improving Influenza Vaccination Rates Among Health Care Professionals

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

Influenza

United States
University of Alabama at Birmingham

Recruiting

Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV) (LAIV)

Influenza, Human

United States
Geisinger Clinic
National Institute on Aging (NIA); Massachusetts Institute of Technology; National...

Completed

High-risk Influenza Vaccine Alert

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Completed

Response to Influenza Vaccine During Pregnancy (FLU-PG)

Influenza

United States
St. Jude Children's Research Hospital

Completed

A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents

Influenza, Human

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Withdrawn

Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood (FLU-LN)

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults

Influenza

United States
KBio Inc

Completed

Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults

Influenza

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)

Influenza

United States
University of Pittsburgh

Completed

Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)

Influenza

United States
National Center for Occupational Health and Infection...
US Department of Veterans Affairs

Terminated

Evaluating Immune Response to Seasonal FluMist in Healthy Adults

Influenza

United States
ModernaTX, Inc.

Completed

Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular Route

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Seroprotection

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients

Influenza

United States
Mark Prausnitz
Emory University

Completed

Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Elderly Influenza Vaccine Immunogenicity Substudy

Influenza

United States
Emory University

Completed

The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination (FLU1)

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People

Influenza

United States
Protein Sciences Corporation

Completed

Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Trial to Describe the Safety and Immunogenicity of Fluzone®

Influenza

United States
MDVI, LLC
United States Department of Defense

Completed

T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza (FAVOR)

Influenza

United States
Columbia University

Completed

TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations

Influenza

United States
Columbia University

Completed

Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children

Influenza

United States
Columbia University

Completed

Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts

Influenza

United States
University of Pittsburgh

Completed

From Innovation to Solutions: Childhood Influenza Vaccination Planning

Influenza

United States
VaxInnate Corporation
University of Colorado, Denver

Completed

Study to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Young Adult Influenza Vaccine Immunogenicity Substudy

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Pilot Study of Genotypic Analysis

Influenza

United States
Akron Children's Hospital

Completed

Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home

Influenza

United States
AlphaVax, Inc.

Completed

A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza (AVX502-003)

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...
Aviron LLC

Completed

Study of a Flu Vaccine in Children

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

St. Jude Open Label H5 Trial

Influenza

United States

Clinical Trials on Influenza in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations